Search found 5 matches
- 18 Apr 2015, 15:16
- Forum: Notes
- Topic: Anticoagulants perioperatively
- Replies: 0
- Views: 13230
Anticoagulants perioperatively
Anticoagulants perioperatively WARFARIN Warfarin is a coumarin derivative It acts by inhibiting vitamin K synthesis and thereby limiting the coagulation factors that are dependent on vitamin K for their production. These include factors II, VII, IX, X and proteins C and S. How does loading of Warf...
- 18 Apr 2015, 14:56
- Forum: Notes
- Topic: BASAL CELL CARCINOMA
- Replies: 0
- Views: 13238
BASAL CELL CARCINOMA
BASAL CELL CARCINOMA Basal cell carcinoma is a slow growing, non-melanoma skin cancer, that is locally invasive. It originates from the basal cell layers of the epidermis. It is the most common types of skin cancer (>75%) affecting the UK population. Common risk factors for BCC Exposure to sunlight...
- 17 Apr 2015, 02:52
- Forum: Break Time
- Topic: Surgery Versus Medicine
- Replies: 0
- Views: 16617
Surgery Versus Medicine
Surgery Versus Medicine Alexa Mieses, Medical Student, 09:46AM Apr 13, 2015 If medicine were the military, surgeons would be the Navy SEALs. They start their day in the wee hours of the morning. They stand in the OR all day, forgoing water, food and bathroom breaks. They remain at the hospital until...
- 17 Apr 2015, 02:48
- Forum: Notes
- Topic: Interferon-free Regimen Effective for Genotype-4 Chronic Hepatitis C
- Replies: 0
- Views: 13432
Interferon-free Regimen Effective for Genotype-4 Chronic Hepatitis C
Interferon-free Regimen Effective for Genotype-4 Chronic Hepatitis C NEW YORK (Reuters Health) - An all-oral, interferon-free regimen consisting of ombitasvir, paritaprevir and ritonavir is effective at treating patients with genotype-4 chronic hepatitis C virus (HCV), according to a new report from...
- 17 Apr 2015, 02:43
- Forum: Notes
- Topic: First Clinical Evidence' of Remyelination in MS
- Replies: 0
- Views: 13312
First Clinical Evidence' of Remyelination in MS
First Clinical Evidence' of Remyelination in MS:- Researchers are reporting what they call "the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis [MS] with a drug therapy." The research team from Biogen report that patients with optic neuriti...